top of page
Ipratropium bromide

異丙托溴銨
Mechanism of action:
Ipratropium bromide 是一種抗膽鹼性支氣管擴張劑(anticholinergic bronchodilator),屬於季銨鹽抗毒蕈鹼劑(quaternary ammonium antimuscarinic agent)。Ipratropium bromide 會抑制毒蕈鹼型乙醯膽鹼受體(muscarinic acetylcholine receptor),包含 M₁、M₂、M₃ 受體,其中以 M₃ 受體為主要臨床作用目標。在正常情況下,副交感神經釋放的乙醯膽鹼會活化呼吸道平滑肌與分泌腺的 M₃ 受體,促使平滑肌收縮並增加黏液分泌。Ipratropium bromide 阻斷 M₃ 受體後,可使支氣管平滑肌放鬆、降低呼吸道阻力並減少黏液分泌。
Reference(s):
1. Rehder KJ et al. (2017). Adjunct therapies for refractory status asthmaticus in children. Respir Care.
2. Seppi K et al. (2011). The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord.
bottom of page
